Literature DB >> 29223424

Outcome After Lung Volume Reduction Surgery in Patients With Severely Impaired Diffusion Capacity.

Claudio Caviezel1, Nadja Schaffter1, Didier Schneiter1, Daniel Franzen2, Ilhan Inci1, Isabelle Opitz1, Walter Weder3.   

Abstract

BACKGROUND: Lung volume reduction surgery (LVRS) has been proven to be a successful procedure and can be performed with low mortality when defined selection criteria are met. We hypothesized good outcome and low mortality after LVRS for selected patients with severe hyperinflation and nonhomogeneous morphology even when diffusion capacity of the lung for carbon monoxide (Dlco) is less than 20%.
METHODS: The study included all patients scheduled for LVRS between March 2005 and May 2014 with a preoperative Dlco of less than 20%. Postoperative 90-day mortality was the primary end point. Secondary end points were postoperative lung function and surgical morbidity at 3, 6, and 12 months.
RESULTS: Included were 33 patients with a median forced expiratory volume in 1 second of 23% (interquartile range, 19% to 28%), a median diffusion capacity of 15% (interquartile range, 13% to 18%), and a median hyperinflation of 76% (residual volume-to-total lung capacity ratio of 70% to 76%). Mean follow-up was 44.8 months (range, 10 to 141 months). Heterogeneous emphysema was present in 26 patients, and 7 showed intermediately heterogeneous morphology. Sixteen procedures were bilateral, and 31 were performed by video-assisted thoracoscopic surgery. The 90-day mortality was 0%. Median forced expiratory volume in 1 second percentage predicted at 3 months increased from 23% to 29% (p < 0.001). Median Dlco increased from 15% to 24% (p < 0.001), and median hyperinflation decreased from 76% to 63% (p < 0.001). A prolonged air leak exceeding 7 days occurred in 16 patients (48.5%), and 6 required reoperation for fistula closure. The 7 patients with intermediately heterogeneous emphysema showed a median increase in forced expiratory volume in 1 second from 20% preoperatively to 28% postoperatively (p = 0.028).
CONCLUSIONS: Selected patients with severely impaired Dlco of less than 20% can cautiously be considered as potential candidates if hyperinflation is severe and the lungs show areas with advanced destruction as targets for resection.
Copyright © 2018 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 29223424     DOI: 10.1016/j.athoracsur.2017.09.006

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  7 in total

Review 1.  Pulmonary hypertension in chronic obstructive pulmonary disease and emphysema patients: prevalence, therapeutic options and pulmonary circulatory effects of lung volume reduction surgery.

Authors:  Isabelle Opitz; Silvia Ulrich
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

2.  Lung volume reduction surgery in patients with low diffusion capacity.

Authors:  Helen Weaver; Neil J Greening; Sridhar Rathinam
Journal:  J Thorac Dis       Date:  2019-03       Impact factor: 2.895

Review 3.  Lung volume reduction surgery beyond the NETT selection criteria.

Authors:  Claudio Caviezel; Didier Schneiter; Isabelle Opitz; Walter Weder
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

4.  Identification of target zones for lung volume reduction surgery using three-dimensional computed tomography rendering.

Authors:  Claudio Caviezel; Tamara Froehlich; Didier Schneiter; Urs Muehlematter; Thomas Frauenfelder; Laura-Chiara Guglielmetti; Isabelle Opitz; Walter Weder
Journal:  ERJ Open Res       Date:  2020-09-14

5.  Endobronchial Valve Treatment in Emphysema Patients with a Very Low DLCO.

Authors:  Marlies van Dijk; Jorine E Hartman; Karin Klooster; Nick H T Ten Hacken; Huib A M Kerstjens; Dirk-Jan Slebos
Journal:  Respiration       Date:  2020-01-21       Impact factor: 3.580

6.  Lung volume reduction surgery as salvage procedure after previous use of endobronchial valves.

Authors:  Claudio Caviezel; Laura-Chiara Guglielmetti; Mateja Ladan; Henrik Jessen Hansen; Michael Perch; Didier Schneiter; Walter Weder; Isabelle Opitz; Daniel Franzen
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-01-22

7.  Endoscopic lung volume reduction with endobronchial valves in very low D LCO patients: results from the German Registry - Lungenemphysemregister e.V.

Authors:  Pavlina Lenga; Christoph Ruwwe-Glösenkamp; Christian Grah; Joachim Pfannschmidt; Jens Rückert; Stephan Eggeling; Sven Gläser; Bernd Schmidt; Paul Schneider; Sylke Kurz; Gunda Leschber; Andreas Gebhardt; Birgit Becke; Olaf Schega; Jakob Borchardt; Ralf-Harto Hübner
Journal:  ERJ Open Res       Date:  2021-01-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.